Unibest

Pharmaceutical intermediates

Gepotidacin Intermediates

2 pharmaceutical intermediates for Gepotidacin. Indication: Urinary Tract Infection (UTI).

提交项目All intermediates

About Gepotidacin

Originator
Glaxosmithkline (Gsk)
Indication
Urinary Tract Infection (UTI)
Approved Date
03/25/2025
NCE Patent
03/25/2035
DS/DP
02/12/2029

Available intermediates

2 intermediates currently listed for Gepotidacin. Request specifications, documentation or a quotation for any item below.

Gepotidacin intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
3,4-Dihydro-2H-pyrano[2,3-c]pyridin-6-ylmethanol527681-60-3//
3,4-dihydro-2H-pyrano[2,3-c]pyridine-6-carbaldehyde527681-61-4//

Other programs under G

GadobutrolGilteritinib

Building toward Gepotidacin?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →